— A weekly roundup of healthcare investigations
by Rachael Robertson, Enterprise & Investigative Writer, MedPage Today
June 10, 2026
• 2 min read
Harvey Risch, MD, PhD, the chair of the President's Cancer Panel, is a co-author on a new paper in Anticancer Research promoting ivermectin and mebendazole as a cancer treatment. The paper is backed by anti-vaccine organizations, including a supplement company known for selling unproven COVID treatments, including ivermectin. Independent experts said the study has a flawed design, methodology, and conclusion. (Important Context)
